ZTO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
ZTO is not a good buy right now. Price action is weakening (negative, expanding MACD histogram) and the pattern-based forward odds skew bearish over the next week/month, while there are no near-term news catalysts or proprietary buy signals to override the technical setup. If you’re impatient and want immediate momentum, this isn’t it; better to wait for either a clean bounce off ~21.58–21.32 support or a reclaim above ~22.45 resistance before stepping in.
Trend/Setup: Mildly bearish to neutral. The stock closed at 21.93, slightly below the pivot (22.016), indicating it’s leaning to the downside. Momentum: MACD histogram -0.0698 is below zero and negatively expanding → downside momentum is building. RSI: RSI(6) ~47.9 (neutral) → not oversold; no reflexive “buy-the-dip” signal. Moving averages: Converging MAs → compression/indecision, but with MACD weakening, risk favors a downside break rather than an upside breakout. Levels: Immediate resistance R1 ~22.447 then R2 ~22.714. Support S1 ~21.584 then S2 ~21.317. A break below ~21.58 increases risk of drifting toward ~21.32. Quant/pattern bias: Similar-pattern stats imply ~70% chance of -1.79% next week and -6.44% next month, reinforcing the near-term bearish tilt.
Intellectia Proprietary Trading Signals
No news in the last week, so there are no obvious event-driven catalysts. Positives are mainly fundamental/structural: steady top-line and EPS growth in the latest reported quarter, and call-leaning options positioning.
No fresh news catalysts to reverse the current technical drift. Near-term technical momentum is weakening (MACD negative and expanding), and the pattern-based outlook points to further downside over the next week/month. Also, gross margin contracted sharply YoY in the latest quarter, which can weigh on sentiment if it persists.
Latest quarter: 2025/Q3. Revenue rose to 1,657,710,260.81 (+11.23% YoY), net income rose to 352,608,886.45 (+5.40% YoY), and EPS increased to 0.43 (+7.50% YoY). The key negative: gross margin fell to 24.91 (down -20.26% YoY), indicating profitability pressure despite growth.
No analyst rating/price target change data was provided, so a recent trend summary can’t be confirmed. From the data available, the ‘Wall Street’ style pros/cons balance would read: Pros—consistent revenue/EPS growth and call-leaning options positioning. Cons—sharp gross margin contraction and currently weakening technical momentum. Net: not a compelling buy at this moment.
